Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline

Gianpiero Manes, Gregorios Paspatis, Lars Aabakken, Andrea Anderloni, Marianna Arvanitakis, Philippe Ah-Soune, Marc Barthet, Dirk Domagk, Jean-Marc Dumonceau, Jean-Francois Gigot, Istvan Hritz, George Karamanolis, Andrea Laghi, Alberto Mariani, Konstantina Paraskeva, Jürgen Pohl, Thierry Ponchon, Fredrik Swahn, Rinze W. F. Ter Steege, Andrea TringaliAntonios Vezakis, Earl J. Williams, Jeanin E. Van Hooft

Research output: Contribution to journalArticle

77 Citations (SciVal)


Gallstones are a very common problem in developed countries [1 – 3]. Most patients with gallstones remain asymptomatic throughout their lifetime [4, 5], but 10%– 25% of them may develop biliary pain or complications [6 – 9], with an annual risk of about 2%– 3% for symptomatic disease [10] and 1%–2% for major complications [11]. The development of symptomatic disease and complications is mostly related to the migration of stones into the common bile duct (CBD). Common bile duct stones (CBDSs) may be treated by endoscopic retrograde cholangiopancreatography (ERCP) or surgically during cholecystectomy. The aim of this evidence- and consensus-based Guideline, commissioned by the European Society of Gastrointestinal Endoscopy (ESGE), is to provide practical advice on how to manage patients with CBDSs. It considers diagnostic strategies in patients with suspected CBDSs, as well as the different therapeutic options available for CBDSs.
Original languageEnglish
Pages (from-to)472-491
Publication statusPublished - 2019


  • Bile duct stones


Dive into the research topics of 'Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline'. Together they form a unique fingerprint.

Cite this